Polymer Factory today announces an order of significant size, as a global life science company has placed an order amounting to approximately SEK 160,000.
Purchasing products from Polymer Factory’s portfolio of dendritic nanomaterials, one of the world’s largest life science companies has placed an order of EUR 16,000, amounting to approximately SEK 160,000. The products purchased are customized and will be used by the customer for product development purposes, possibly leading to further business opportunities for the Company upon successful evaluation.
A single order of this size is significant to Polymer Factory at this stage in the company growth and building business relationships with companies of this magnitude is strategically important.
CEO Elin Mignérus comments:
“Our dendritic nanomaterial platform has unlimited potential in the life science sector, ranging from therapeutic to diagnostic applications. The fact is, since becoming a public Company, we have secured customized orders of significant size from two global life science companies. This foretells the demand and interest for our dendritic products among life science companies and underlines the quality and unique position of our Company. The Company’s goal is to help our customers succeed by leveraging the benefits of dendritic amplification, and we are always working to bring these collaborations into long-term relationships.”
This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 31 January 2022.
Find the full press release here: